News Foley Represents Bioluminescence Ventures in Emergence from Stealth with $477M AUM Foley & Lardner LLP represented Bioluminescence Ventures in its emergence from stealth with $477M in…Louis LehotNovember 1, 2023
News Louis Lehot and Eric Chow Author Article on Biotech Sector’s M&A Pipeline Foley & Lardner LLP partners Louis Lehot and Eric Chow authored the GEN article, “Strengthening the Flow…Louis LehotOctober 10, 2023
News Louis Lehot Offers Insight on Diversity Disclosures for Venture Funds Foley & Lardner LLP partner Louis Lehot was quoted in the Daily Journal article, "Lawyers Cautiously Approve…Louis LehotOctober 10, 2023
News Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million…Louis LehotSeptember 27, 2023
News Louis Lehot and Christopher Swift Comment on U.S.-China “Decoupling” Foley & Lardner LLP partners Louis Lehot and Christopher Swift are quoted in the IFLR…Louis LehotSeptember 19, 2023
News Foley Represents Trading Technologies in Acquisition of Abel Noser Solutions Foley & Lardner LLP represented Trading Technologies International, Inc. (TT), a global capital markets technology…Patrick DaughertySeptember 11, 2023
News Louis Lehot and Eric Chow Assess How AI is Disrupting Dealmaking Foley & Lardner LLP partners Louis Lehot and Eric Chow authored the Westlaw article, “How artificial intelligence…Louis LehotSeptember 8, 2023
News Foley Attorneys Discuss Preparation for New U.S. Outbound Investment Regime Foley & Lardner LLP partners Louis Lehot and Christopher Swift are quoted in the IFLR article, “Law…Louis LehotSeptember 6, 2023
News Foley Represents TCGX as a Lead Investor in $285M Financing for COMPASS Pathways Foley & Lardner LLP represented TCGX as a lead investor in the $285 million financing…Louis LehotSeptember 6, 2023
News Foley Represents TCGX as a Lead Investor in $200M Series C Financing for ADARx Foley & Lardner LLP represented TCGX as a lead investor in the oversubscribed $200 million…Louis LehotSeptember 6, 2023